Plant ID: NPO6836
Plant Latin Name: Alpinia blepharocalyx
Taxonomy Genus: Alpinia
Taxonomy Family: Zingiberaceae
NCBI TaxonomyDB:
105668
Plant-of-the-World-Online:
n.a.
China
NPSR1; TSHR; | |
CA2; CA14; CA7; CA12; CA1; CA9; | |
HSD17B3; ALDH1A1; | |
TP53; | |
F3; LMNA; THPO; |
Cytochrome P450 Enzymes: | CYP19A1; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Enzyme_unclassified | HSD17B3 | Estradiol 17-beta-dehydrogenase 3 | P37058 | CHEMBL4234 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | F3 | Coagulation factor III | P13726 | CHEMBL4081 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 4.827E-13 | 5.256E-09 | CA1, CA12, CA14, CA2, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 4.988E-11 | 2.172E-07 | CA1, CA12, CA2, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 1.688E-06 | 4.594E-03 | CA2, CA7 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 3.463E-16 | 7.540E-12 | CA1, CA12, CA14, CA2, CA7, CA9 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 6.944E-16 | 4.097E-14 | CA12, CA1, CA2, CA7, CA9, CA14 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR; |
I00-I99: Diseases of the circulatory system | Neurological disease | I21, I22, R52, R52.1-R52.2, R60.9, G89 | NPSR1; |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR; |
C00-D49: Neoplasms | Cancer | C00-C96 | TP53; CA1; CA9; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | F3; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TP53; |
I00-I99: Diseases of the circulatory system | Renal artery disease | I70.1 | TP53; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Toxicity | T36-T50, T51-T65 | TP53; |
N00-N99: Diseases of the genitourinary system | Endometriosis | N80 | CYP19A1; |
N00-N99: Diseases of the genitourinary system | Prostate disease | N42.9 | CYP19A1; |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |
H00-H59: Diseases of the eye and adnexa | Chronic glaucoma | H40-H42 | CA1; |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TP53; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | TP53; CA9; |
C00-D49: Neoplasms | Breast cancer | C50 | CYP19A1; CA9; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; CA1; |
I00-I99: Diseases of the circulatory system | Bleeding | I74, I80-I82 | F3; |
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | CA1; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | TP53; |
H60-H95: Diseases of the ear and mastoid process | Hearing disorder | H90.5 | TP53; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1; |
J00-J99: Diseases of the respiratory system | Adult respiratory distress syndrome | J80 | F3; |
C00-D49: Neoplasms | Advanced breast cancer | C50 | CYP19A1; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
NA: NA | Edema | NA | CA2; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | TP53; |